All Categories / Pharmacology & Pharmacy / Top 10 by Impact Factor

Top 10 Pharmacology & Pharmacy Journals by Impact Factor

Compare leading Pharmacology & Pharmacy journals ranked by Journal Impact Factor. Each journal summary highlights key details authors often need when choosing where to submit, including publisher, impact factor, open access status, identifiers, and available submission profile information.

Rankings are based on the latest Journal Impact Factor data currently available in our journal database.

#1
NR
JIF 101.8
Q1
Hybrid

Nature Reviews Drug Discovery is a journal covering drug discovery and development, featuring Reviews, Perspectives, Comments, News in Brief, Research Highlights and related analysis on therapeutics, targets, clinical trials, regulatory science and biopharma t...

Identifiers

ISSN 1474-1776
eISSN 1474-1784

Publication Cost

Subscription publication route only; no immediate gold open access publication option.

Publishing Timeline

Monthly journal.
#2
DR
JIF 21.7
Q1
Hybrid

Drug Resistance Updates publishes original research, commentary, and expert reviews on drug resistance in infectious disease and cancer, as well as novel drugs and strategies to overcome resistance. It covers both basic research and clinical aspects of drug re...

Identifiers

ISSN 1368-7646
eISSN 1532-2084

Publication Cost

USD 5320 APC for open access publication; no open access publication fee for subscription publication.

Publishing Timeline

2 days submission to first decision; 33 days submission to decision after review; 88 days submission to acceptance; 3 days acceptance to online publication
#3
TI
JIF 19.9
Q1
Hybrid

Trends in Pharmacological Sciences (TIPS) is a monthly peer-reviewed reviews journal that publishes reviews and opinions across pharmacology, pharmacy, pharmaceutics, and toxicology. Launched in 1979, it focuses on recent developments in pharmacology and thera...

Identifiers

ISSN 0165-6147
eISSN 1873-3735

Publication Cost

Subscription-based pricing; prices are displayed in US dollars for consistency, with billing currency varying by region.

Publishing Timeline

1 day submission to first decision; 50 days submission to acceptance
#4
AD
JIF 17.6
Q1
Hybrid

Advanced Drug Delivery Reviews publishes commissioned review articles in Theme Issue format on advanced drug and gene delivery systems and their applications in human and veterinary medicine. The journal covers key issues in effective drug and gene delivery, f...

Identifiers

ISSN 0169-409X
eISSN 1872-8294

Publication Cost

USD 5470 APC for open access; no open access publication fee for subscription articles.

Publishing Timeline

5 days submission to first decision; 51 days submission to decision after review; 116 days submission to acceptance; 3 days acceptance to online publication
#5
PR

American Society for Pharmacology and Experimental Therapeutics

JIF 17.3
Q1
Hybrid

Pharmacological Reviews presents important review articles covering the broad spectrum of pharmacological research, including biochemical and cellular pharmacology, drug metabolism and disposition, renal pharmacology, neuropharmacology, behavioral pharmacology...

Identifiers

ISSN 0031-6997
eISSN 1521-0081

Publication Cost

Open access APC: USD 4500 for full length articles; USD 3150 for short articles; ASPET members receive a 25% discount. Subscription publication has no open access publication fee.

Publishing Timeline

121 days submission to acceptance
#6
AP
JIF 14.6
Q1
Open

Acta Pharmaceutica Sinica B is a monthly English-language peer-reviewed journal that publishes significant original research articles, rapid communications, and high quality reviews across pharmaceutical sciences, including pharmacology, pharmaceutics, medicin...

Identifiers

ISSN 2211-3835
eISSN 2211-3843

Publication Cost

Article Publishing Charge: USD 2600 for Full Length Articles and Reviews; USD 2000 for Short Articles, excluding taxes.

Publishing Timeline

6 days submission to first decision; 38 days submission to decision after review; 210 days submission to acceptance; 5 days acceptance to online publication
#7
Dr

Adis, Springer Healthcare

JIF 14.4
Q1
Hybrid

Drugs is a journal focused on therapeutics and drug information. For over 50 years it has published reviews and original clinical research on new and established drug therapies across all disease areas to support clinical decision-making through peer-reviewed...

Identifiers

ISSN 0012-6667
eISSN 1179-1950

Publication Cost

Open access APC: £4190.00 GBP / $6290.00 USD / €4990.00 EUR; subscription publishing: no APC charges apply.

Publishing Timeline

Submission to first decision (median): 8 days
#8
AR
JIF 13.1
Q1
Open

Annual Review of Pharmacology and Toxicology covers significant developments in pharmacology and toxicology, including receptors, transporters, enzymes, chemical agents, drug development science, physiological systems such as the immune, central and autonomic...

Identifiers

ISSN 0362-1642
eISSN 1545-4304
#9
P&
JIF 12.5
Q1
Hybrid

Pharmacology & Therapeutics publishes lucid, critical, and authoritative reviews on important topics in pharmacology, including drug actions and the exploitation of drug targets. Disease pathophysiology is covered when it forms part of a narrative around drug...

Identifiers

ISSN 0163-7258
eISSN 1879-016X

Publication Cost

Open access APC: USD 5380 excl. taxes for all articles; subscription publication has no open access publication fee.

Publishing Timeline

9 days submission to first decision; 56 days submission to decision after review; 146 days submission to acceptance; 4 days acceptance to online publication.
#10
AJ
JIF 11.9
Q1
Hybrid

Asian Journal of Pharmaceutical Sciences (AJPS) is the official journal of the Asian Federation for Pharmaceutical Sciences and is indexed by Science Citation Index Expanded. It publishes innovations, production methods, technologies, initiatives, and applicat...

Identifiers

ISSN 1818-0876
eISSN 1818-0876

Publication Cost

No open access publication fee for authors; Shenyang Pharmaceutical University pays the APC.

Publishing Timeline

6 days submission to first decision; 59 days submission to decision after review; 159 days submission to acceptance
Preparing a manuscript for a high-impact journal?

Livewrite works inside Microsoft Word to help researchers write, edit, cite, review, and format manuscripts for journal submission.